Correlation Between Biomea Fusion and Taysha Gene

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Biomea Fusion and Taysha Gene at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Biomea Fusion and Taysha Gene into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Biomea Fusion and Taysha Gene Therapies, you can compare the effects of market volatilities on Biomea Fusion and Taysha Gene and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Biomea Fusion with a short position of Taysha Gene. Check out your portfolio center. Please also check ongoing floating volatility patterns of Biomea Fusion and Taysha Gene.

Diversification Opportunities for Biomea Fusion and Taysha Gene

0.16
  Correlation Coefficient

Average diversification

The 3 months correlation between Biomea and Taysha is 0.16. Overlapping area represents the amount of risk that can be diversified away by holding Biomea Fusion and Taysha Gene Therapies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Taysha Gene Therapies and Biomea Fusion is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Biomea Fusion are associated (or correlated) with Taysha Gene. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Taysha Gene Therapies has no effect on the direction of Biomea Fusion i.e., Biomea Fusion and Taysha Gene go up and down completely randomly.

Pair Corralation between Biomea Fusion and Taysha Gene

Given the investment horizon of 90 days Biomea Fusion is expected to generate 1.09 times more return on investment than Taysha Gene. However, Biomea Fusion is 1.09 times more volatile than Taysha Gene Therapies. It trades about 0.12 of its potential returns per unit of risk. Taysha Gene Therapies is currently generating about -0.54 per unit of risk. If you would invest  392.00  in Biomea Fusion on November 5, 2024 and sell it today you would earn a total of  26.00  from holding Biomea Fusion or generate 6.63% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Biomea Fusion  vs.  Taysha Gene Therapies

 Performance 
       Timeline  
Biomea Fusion 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Biomea Fusion has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's technical and fundamental indicators remain somewhat strong which may send shares a bit higher in March 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
Taysha Gene Therapies 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Taysha Gene Therapies are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak technical indicators, Taysha Gene sustained solid returns over the last few months and may actually be approaching a breakup point.

Biomea Fusion and Taysha Gene Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Biomea Fusion and Taysha Gene

The main advantage of trading using opposite Biomea Fusion and Taysha Gene positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Biomea Fusion position performs unexpectedly, Taysha Gene can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Taysha Gene will offset losses from the drop in Taysha Gene's long position.
The idea behind Biomea Fusion and Taysha Gene Therapies pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.

Other Complementary Tools

Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities